Sino Biological,Inc. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	2017 - 2019
Cash & Equivalents	407.64	233.35	1,316	2,380	2,872	56.12	Upgrade
Trading Asset Securities	2,854	3,716	3,533	3,422	3,638	1,073	Upgrade
Cash & Short-Term Investments	3,262	3,949	4,849	5,802	6,511	1,129	Upgrade
Cash Growth	-16.54%	-18.55%	-16.43%	-10.88%	476.77%	2067.15%	Upgrade
Accounts Receivable	179.95	151.44	126.33	141.08	154.07	195.49	Upgrade
Other Receivables	8.87	20.18	22.07	15.66	6.18	1.77	Upgrade
Receivables	188.82	171.63	148.4	156.74	160.25	197.27	Upgrade
Inventory	78.54	64.4	52.53	47.49	24.75	14.25	Upgrade
Prepaid Expenses	-	5.45	6.63	-	6.35	-	Upgrade
Other Current Assets	27.67	16.61	12.65	17.72	16.74	18.33	Upgrade
Total Current Assets	3,557	4,208	5,069	6,024	6,719	1,359	Upgrade
Property, Plant & Equipment	863.5	893.55	900.9	210.96	107.57	52.41	Upgrade
Long-Term Investments	321.44	229.17	215.94	180.24	-	-	Upgrade
Goodwill	281.66	278.38	-	-	-	-	Upgrade
Other Intangible Assets	41.5	44.79	0.8	1.11	0.92	0.38	Upgrade
Long-Term Deferred Tax Assets	113.93	113.81	104.63	80.28	38.26	46.56	Upgrade
Long-Term Deferred Charges	53.04	59.69	59.73	49	9.31	7.01	Upgrade
Other Long-Term Assets	245.94	227.74	249.64	34.64	15.34	-	Upgrade
Total Assets	5,478	6,055	6,601	6,580	6,890	1,465	Upgrade
Accounts Payable	19.56	18.21	19.33	29.23	4.25	6.89	Upgrade
Accrued Expenses	36.84	46.04	54.3	44.09	36.02	62.08	Upgrade
Current Portion of Leases	16.21	22.47	23.37	19.81	20.45	-	Upgrade
Current Income Taxes Payable	11.21	10.3	3.05	6.76	11.94	74.66	Upgrade
Current Unearned Revenue	31.2	29.85	22.74	20.71	13.81	9.36	Upgrade
Other Current Liabilities	12.71	70.64	13.58	4.6	11.89	7.83	Upgrade
Total Current Liabilities	127.74	197.52	136.38	125.2	98.37	160.82	Upgrade
Long-Term Leases	35.84	44.9	61.69	50.65	26.9	-	Upgrade
Long-Term Unearned Revenue	2.42	2.54	4.22	5.63	-	-	Upgrade
Long-Term Deferred Tax Liabilities	34.81	36.84	31.41	29.64	12.65	5.56	Upgrade
Total Liabilities	200.81	281.8	233.7	211.11	137.92	166.38	Upgrade
Common Stock	121.64	121.64	129.2	129.2	68	51	Upgrade
Additional Paid-In Capital	4,354	4,353	4,796	4,793	4,853	141.86	Upgrade
Retained Earnings	802.23	1,300	1,434	1,432	1,809	1,089	Upgrade
Comprehensive Income & Other	-0.56	-1.48	7.97	14.51	22.11	16.55	Upgrade
Shareholders' Equity	5,277	5,773	6,367	6,369	6,752	1,299	Upgrade
Total Liabilities & Equity	5,478	6,055	6,601	6,580	6,890	1,465	Upgrade
Total Debt	52.05	67.37	85.06	70.46	47.36	-	Upgrade
Net Cash (Debt)	3,210	3,882	4,764	5,732	6,463	1,129	Upgrade
Net Cash Growth	-16.39%	-18.51%	-16.89%	-11.32%	472.58%	2067.15%	Upgrade
Net Cash Per Share	25.99	30.34	36.87	50.32	60.03	11.65	Upgrade
Filing Date Shares Outstanding	121.64	121.64	129.2	129.2	129.2	96.9	Upgrade
Total Common Shares Outstanding	121.64	121.64	129.2	129.2	129.2	96.9	Upgrade
Working Capital	3,429	4,010	4,933	5,899	6,620	1,198	Upgrade
Book Value Per Share	43.38	47.46	49.28	49.30	52.26	13.40	Upgrade
Tangible Book Value	4,954	5,450	6,366	6,368	6,751	1,298	Upgrade
Tangible Book Value Per Share	40.73	44.80	49.27	49.29	52.26	13.40	Upgrade
Buildings	-	637.92	637.92	-	-	-	Upgrade
Machinery	-	300.85	268.29	200.86	105.49	88.17	Upgrade
Construction In Progress	-	44.49	8.55	-	-	-	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.